生命科学资讯

GSK explores frontiers of siRNA with $1B deal for 2 drugs from Chinese biotech

Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics

Abcuro's KLRG1 antibody flunks phase 2/3 muscle disease study

Allurion stock balloons as FDA signs off on its weight loss gastric system

Medtronic's diabetes business MiniMed eyes $784M IPO

Patient dies in MacroGenics' cancer study, FDA puts trial on hold

Beam Therapeutics' new PKU program; Protara's bladder cancer data

Abcuro drug fails muscle weakness trial, development to continue

Appointments and advancements for Feb. 24, 2026

Financings for Feb. 24, 2026

In the clinic for Feb. 24, 2026

Other news to note for Feb. 24, 2026

Regulatory actions for Feb. 24, 2026

How Enzymes Are Powering A New Generation of Micro-Robots

Immedica wins accelerated approval for once-rejected rare disease drug

Novo, searching for a spark, spotlights new data for three-pronged obesity drug

How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga

Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - Business Wire

Will the FDA yank mRNA vaccines?

New biotech Slate Medicines raises $130M for migraine drug from China